AGT and Alzheimer disease: Most recently and comprehensively, a study in approximately 58,000 Medicare beneficiaries with newly discovered hypertension with 2000 incident dementia cases during 12 years of follow-up, found 16% lower AD and related dementias risk associated with Ang-II-stimulating versus Ang-II-inhibiting AHM-use.19